|
Actonel significantly reduced osteoporotic fractures in high-risk postmenopausal women, at one year.
Publication: Asia Africa Intelligence Wire Publication Date: 10-FEB-03 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2003 Financial Times Ltd.
(From Chemical Business NewsBase - Press Release)
Newly published data show that treatment with 5 mg Actonel (risedronate sodium tablets) daily reduced the risk of spinal fracture in postmenopausal osteoporotic patients at higher risk of fracture because of age or low bone mineral density (BMD) at the hip. In these patients, fracture risk was reduced by 62% and...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Asia Africa Intelligence Wire |
Chevron wins patents on gasolines containing ethanol.
January 31, 2003
|
Upturn expected for 2003.
January 31, 2003
|
Titanium dioxide price increases.
January 31, 2003
|
A rise in Latex.
January 31, 2003
|
Polymer demand to reach #4.9 bn in 2006.
January 31, 2003
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
